Abstract

Severe sepsis can be a catastrophic condition that is often associated with poor outcomes.
The early diagnosis and management of the condition are vital in order to improve
the chances of survival. However, owing to the syndromal nature of its definition
and the lack of a biomarker able to accurately confirm the condition, the diagnosis
of sepsis is challenging. Even more challenging is the prediction of how these patients
will respond to the therapy and whether they will survive the intensive care and the
hospital admission.